Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and 18F-FDG PET/CT

Seunghyun Ahn1, Jeong Min Lee2, Ijin Joo1, Eun Sun Lee3, Soo Jin Lee4, Gi Jeong Cheon5,4, Joon Koo Han6,1, Byung Ihn Choi1,6
1Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
2Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital, #101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea
3Department of Radiology, National Cancer Center, Goyang, Korea
4Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
5Cancer Research Institute, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
6Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576

Kurtovic J, Riordan SM, Williams R (2005) Liver transplantation for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19:147–160

Zimmerman MA, Ghobrial RM, Tong MJ, et al. (2008) Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg 143:182–188

Shetty K, Timmins K, Brensinger C, et al. (2004) Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 10:911–918

Gouw AS, Balabaud C, Kusano H, et al. (2011) Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl 17:S72–S80

Kim KA, Kim MJ, Jeon HM, et al. (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634

Kim H, Park MS, Choi JY, et al. (2009) Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol 19:1744–1751

Chandarana H, Robinson E, Hajdu CH, et al. (2011) Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? Am J Roentgenol 196:1083–1089

Kornberg A, Freesmeyer M, Barthel E, et al. (2009) 18F-FDG-Uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant 9:592–600

Zech CJ, Vos B, Nordell A, et al. (2009) Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA. Invest Radiol 44:305–310

Lee MW, Lee JM, Lee JY, et al. (2006) Preoperative evaluation of the hepatic vascular anatomy in living liver donors: comparison of CT angiography and MR angiography. J Magn Reson Imaging 24:1081–1087

Nakashima Y, Nakashima O, Tanaka M, et al. (2003) Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 26:142–147

Lee JW, Paeng JC, Kang KW, et al. (2009) Prediction of tumor recurrence by F-18-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med 50:682–687

Miyata R, Tanimoto A, Wakabayashi G, et al. (2006) Accuracy of preoperative prediction of microinvasion of portal vein in hepatocellular carcinoma using superparamagnetic iron oxide-enhanced magnetic resonance imaging and computed tomography during hepatic angiography. J Gastroenterol 41:987–995

Matsui O, Kobayashi S, Sanada J, et al. (2011) Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 36:264–272

Cheung TT, Chan SC, Ho CL, et al. (2011) Can positron emission tomography with the dual tracers [C-11] acetate and [F-18] fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? Liver Transpl 17:1218–1225

Kim BK, Kang WJ, Kim JK, et al. (2011) 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma. Cancer 117:4779–4787

Rodriguez-Peralvarez M, Luong TV, Andreana L, et al. (2013) A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 20:325–339

Adam P, McMaster P, O’Grady JG, et al. (2003) Evolution of liver transplantation in Europe: Report of the European liver transplant registry. Liver Transplant 9:1231–1243

Broelsch CE, Malago M, Testa G, Gamazo CV (2000) Living donor liver transplantation in adults: outcome in Europe. Liver Transplant 6:S64–S65

Clavien PA, Lesurtel M, Bossuyt PMM, et al. (2012) Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 13:E11–E22

Schroeder T, Malago M, Debatin JE, et al. (2005) “All-In-One” imaging protocols for the evaluation of potential living liver donors: comparison of magnetic resonance imaging and multidetector computed tomography. Liver Transpl 11:776–787

Hwang S, Lee SG, Belghiti J (2010) Liver transplantation for HCC: its role—Eastern and Western perspectives. J Hepatobiliary Pancreat Sci 17:443–448

Liang WH, Wu LW, Ling XT, et al. (2012) Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl 18:1226–1236

Mazzaferro V, Regalia E, Doci R, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New Engl J Med 334:693–699

Prasad KR, Young RS, Burra P, et al. (2011) Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl 17(Suppl 2):S81–S89

Mazzaferro V, Llovet JM, Miceli R, et al. (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43

Young AL, Lodge JP (2009) Needle-track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 58(6):887–888

Sacks A, Peller PJ, Surasi DS, et al. (2011) Value of PET/CT in the management of primary hepatobiliary tumors, part 2. Am J Roentgenol 197:W260–W265

Khan MA, Combs CS, Brunt EM, et al. (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32:792–797

Park JW, Kim JH, Kim SK, et al. (2008) A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49:1912–1921

Schwenzer NF, Schmidt H, Claussen CD (2012) Whole-body MR/PET: applications in abdominal imaging. Abdom Imaging 37:20–28

Pichler BJ, Kolb A, Nagele T, Schlemmer HP (2010) PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med 51:333–336

Choi JW, Lee JM, Kim SJ et al. (2013) Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR images and their value as an imaging biomarker. Radiology 267(3):776–786

Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. development, growth, and spread: key pathologic and imaging aspects. Radiology 272(3):635–654